Merck
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Merck was mentioned 44 times in 26 outlets across 6 countries over the last 12 months. 75% of that coverage was positive and 5% negative.
MENTIONS · 12M
44
49 all-time
OUTLETS · 12M
26
in 6 countries
AVG SENTIMENT
+0.520
Recent coverage
Merck (NYSE:MRK) Gains Attention As Cancer Vaccine Progress Builds - Kalkine Media
kalkinemedia.com · INT · 31 Aug 2026 · positive
Susquehanna Fundamental Investments LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
marketbeat.com · INT · 31 Aug 2026 · neutral
South Korean Retail Investors Pivot Away From Semiconductors, Pile Into Merck and Crypto With $800 Million Weekly Net Buying - finance.biggo.com
finance.biggo.com · KR · 31 Aug 2026 · positive
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging - Yahoo Finance
finance.yahoo.com · INT · 31 Aug 2026 · positive
Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma Therapy - Yahoo Finance
finance.yahoo.com · INT · 30 Aug 2026 · positive
Thornburg Investment Management Inc. Acquires 59,303 Shares of Merck & Co., Inc. $MRK - MarketBeat
marketbeat.com · INT · 30 Aug 2026 · positive
Merck & Co., Inc. $MRK Shares Sold by Washington Trust Bank - MarketBeat
marketbeat.com · INT · 30 Aug 2026 · positive
Merck & Co., Inc. $MRK Shares Purchased by Alyeska Investment Group L.P. - MarketBeat
marketbeat.com · INT · 30 Aug 2026 · positive
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 0 |
| 2026-01 | 0 |
| 2026-02 | 0 |
| 2026-03 | 0 |
| 2026-04 | 1 |
| 2026-05 | 0 |
| 2026-06 | 1 |
| 2026-07 | 0 |
| 2026-08 | 42 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Merck against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page